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WAbstract
Backround and Airns: Therc are several known mcthods fbr cancer treatrncnts which arc one
rnethod of treatment is itnmunotherapy. Live attenuated recorlbinant vector vaccine is one of
the methods of immunotherapy. Tltis vectors can bc used for a delivery system for tumor-
associated atltigen in tumor itnruunotherapy. Prostate-specific antigcn (PSA) incrcase in
patients rvith prostate cancer and could be a target fbr treatment of proslate cancer. In this
artiole, we used the attcnuated line o{'leishnrania major (H-line) that previously attenuatecl
with gentamicin by l-lamid Daneshvar. He dcrnonstratcd that attenuated strain of leishrnania
nrajor is safe.'fhc airn of this studyrvas to cloning PSA genc into attcnuated lcishnrarrianrajor
(II-linc) and evaluate o1'the safty of rcconrbinant lcishmania nrajor in BALB/c mousc.
N{aterial and Methods: In the prcsent study, rvc cloncd human PSA genc into attenuated
leisltrnania lnajor and lve detectcd exprcssion of I'}SA gcuc in recourbinanl Leishrnania ma.ior
by wcstern blotting. To exatrine the saltty of the transgenic parasite , groups of 5 BALLI/c
ntice were injectcd subcutanconsly rvith stationary-phase L. rnajor lvild , IJ-line, recombiuant
promastigotes. 'fhc [esiott volutne \,vas lllcasllred rveekly rvith a capitlary micrometer.
'['o investigate the ability of promastigotes to inl'cct macrophages and thcir survival rvithin
macrophages, peritoneal lnacropharrcs were cxposcd to stationarl,-phasc promastigotes. The
cultureslidesthenrvereincubatcdin5'/oCO2,95o airforB.48,96hat37'C..Attheenclof
the incubation period. the macrophages rvere fixcd and stained with Giernsa stain ,ancl the
infection status of the rnacrophages was detcnnined by rnicroscopy.
Results: The PSA gene cloned irtto leishrnania maior Il-line successlully for first time and we
could detected expression of'PSA genc in leshrnania major I-l-line. Saf-ety evaluated by 2
criteria: first .that promastigotes o1' the recombinant leshrnania rnajor coulcl enter but not
survive in ntacrophages, and second, that uricc inoculatcd subcutaneously r.vith attenuated
parasites did not develop skin lesions.
Conclusions: f'hese finding represent that lcishrrania rnajor I-l-line could be used as a llew
vector vaccinc {br cxpression of 'l'AAs and othcr proteins that can not express to other
delivery systems. The use of live attenuatcd Lcishmania m{or preparations as candidate
vaccines is very prornising because thcy most close ly lnintic the natural course of infection
and may, therefore, elicit similar irnmune rcsponscs.
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